Editor's Note
Roux-en-Y gastric bypass surgery kept type 2 diabetes in remission for up to 15 years and maintained most of the weight loss for up to 20 years in a long-term study, according to a June 12 report in SciTech Daily.
Presented the same day at The American Society for Metabolic & Bariatric Surgery (ASMBS) Annual Scientific Meeting, the study analyzed 2,045 patients who underwent the surgery at Geisinger Medical Center in Danville, Pennsylvania between 2001 and 2008, the outlet reports. Key findings include:
Centers for Disease Control and Prevention (CDC) estimates indicate that obesity, which can cause health conditions ranging from cardiovascular disease to cancer, affects 42.4% of Americans, SciTech Daily reports. However, ASMBS reports that only 1% of those who meet BMI criteria for bariatric surgery underwent the procedure in 2022. Amid the proliferation of other forms of treatment, lead authors say this demonstration of long-term effectiveness is important for ensuring patients receive the right interventions at the right time.
Read More >>